Myelofibrosis (MF) – Page 2 – MPN Research Foundation
Skip to content
MPN Research Foundation
Search for...
Menu
RESEARCH
Research Impact
MPN Challenge™
MPN Roundtable™
Patient-Focused Drug Development
2022 Thrive Initiative
MPN Interferon Initiative
Apply For Research Funding
PATIENTS & CAREGIVERS
MPN Clinical Trials
Patient & Caregiver Stories
Patient & Caregiver Resources
Living with an MPN
Find Support
UNDERSTANDING MPNS
Essential Thrombocythemia (ET)
Polycythemia Vera (PV)
Myelofibrosis (MF)
30 Facts about MPNs
Glossary
SUPPORT US
Make a Donation
Other Ways to Give
Create Your Own Fundraiser
ABOUT MPNRF
Our Mission & History
Board of Directors
Our Team
Scientific Advisory Board
News & Articles
Newsletters
Our Partners
DONATE
JOIN COMMUNITY
Myelofibrosis (MF)
Myelofibrosis (MF)
Pacritinib
by
MPNRF
March 11, 2021
AVID200
by
MPNRF
March 11, 2021
Fedratinib
by
MPNRF
March 11, 2021
KRT-232
by
MPNRF
March 11, 2021
CALR Exon 9 Mutant Peptide Vaccine
by
MPNRF
March 11, 2021
Ruxolitinib + Pevonedistat
by
MPNRF
March 11, 2021
Ruxolitinib + Chemotherapy
by
MPNRF
March 11, 2021
Cyclophosphamide
by
MPNRF
March 11, 2021
Givinostat
by
MPNRF
March 11, 2021
CPI-0610 +/- Ruxolitinib
by
MPNRF
March 11, 2021
« Previous
1
2
3
4
Next »